Please Wait

Applying Filters...

Annual Sales of Zolpidem reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Zolpidem

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

63 API Suppliers, 34 USDMF, 22 CEP/COS, 12 JDMF, 11 EU WC, 9 KDMF, 11 NDC API, 27 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

5 API Suppliers

5 API Suppliers

FINISHED DOSAGE FORMULATIONS

263 FDF Dossiers, 82 FDA Orange Book, 121 Europe, 12 Canada, 22 South Africa, 26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 5MG, TABLET, EXTENDED RELEASE;ORAL - 12.5MG, TABLET, EXTENDED RELEASE;ORAL - 6.25MG, SPRAY, METERED;ORAL - 5MG/SPRAY, TABLET;SUBLINGUAL - 1.75MG, TABLET;SUBLINGUAL - 3.5MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 5 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 5 DKSH, 3 Jai Radhe Sales, 1 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 17 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 36 BASF, 1 Bioplus Life Sciences, 2 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 15 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 77 Coating Systems & Additives, 51 Direct Compression, 47 Disintegrants & Superdisintegrants, 45 Controlled & Modified Release, 33 Taste Masking, 31 Granulation, 31 Solubilizers, 30 Thickeners and Stabilizers, 26 Lubricants & Glidants, 26 Film Formers & Plasticizers, 21 Chewable & Orodispersible Aids, 21 Parenteral, 19 Topical, 19 Co-Processed Excipients, 8 API Stability Enhancers, 8 Emulsifying Agents, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 38 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 113 Finished Drug Prices, 13 Annual Reports

MARKET PLACE

10 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

13 US Patents, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 10 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

13 All

01 7Myslee

02 4Myslee/Ambien/Stilnox

03 1Stilnox

04 1Stilnox/Ambien/Myslee

List of Suppliers

Product Main Page

01

Brand Name : Myslee/Ambien/Stilnox

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 239

2018 Revenue in Millions : 252

Growth (%) : -5

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

02

Brand Name : Stilnox

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Zolpidem Tartrate

Main Therapeutic Indication : Sleep Disorders

Currency : USD

2014 Revenue in Millions : -21.70%

2013 Revenue in Millions :

Growth (%) :

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

03

Brand Name : Stilnox/Ambien/Myslee

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Zolpidem Tartrate

Main Therapeutic Indication : Sleep Disorders

Currency : USD

2015 Revenue in Millions : 337

2014 Revenue in Millions : 337

Growth (%) : 0%

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

04

Brand Name : Myslee/Ambien/Stilnox

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Zolpidem Tartrate

Main Therapeutic Indication : Sleep Disorders

Currency : USD

2016 Revenue in Millions : 322

2015 Revenue in Millions : 324

Growth (%) : -1

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

05

Brand Name : Myslee/Ambien/Stilnox

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Zolpidem Tartrate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 321

2016 Revenue in Millions : 377

Growth (%) : -15

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

06

Brand Name : Myslee/Ambien/Stilnox

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Zolpidem Tartrate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 261

2017 Revenue in Millions : 293

Growth (%) : -11%

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

07

Brand Name : Myslee

Luxepack

Not Confirmed

08

Brand Name : Myslee

Luxepack

Not Confirmed

09

Brand Name : Myslee

Luxepack

Not Confirmed

10

Brand Name : Myslee

Zolpidem Tartrate

Luxepack

Not Confirmed

1
2

Contact us
to update this info